This Shanghai-based biotech firm operates a research-heavy organization (32 research staff) focused on antibody development, cell culture optimization, and pharmacokinetic modeling—evidenced by active projects spanning downstream purification, PKPD modeling, and clinical trial support. The tech stack (NONMEM, WinNonlin, LC-MS/MS, SAS, Python, SAP, 用友) reflects pharmaceutical-grade analytical and manufacturing systems typical of pre-commercial biotech. Pain points cluster around high-throughput screening, production scaling, yield improvement, and regulatory audit readiness, alongside an explicit IPO preparation workstream—all consistent with a company transitioning from R&D-stage to manufacturing maturity.
Tech Stack 20 technologies
What 哈达国际物流(上海)有限公司 Is Building
◆Challenges
- High-throughput screening of antibody-producing cell lines
- Compliance with national regulations
- Data reliability verification
- Scaling up production
- Audit readiness
- Large-scale antibody production
- Energy consumption reduction
- Improving yield
- Reducing production costs
- Preparing for ipo
▲Active Projects
- Product release and stability studies
- Downstream purification process development
- Analysis method development and validation
- Clinical trial pharmacokinetics support
- Quality risk management system
- Cell culture process development plan design
- Ipo preparation
- Sop development and revision
- Pkpd modeling
- Tax refund processing
Hiring Activity
Department
Seniority
Notable leadership hires: Office Director, Medical Director, Chief Financial Officer, Quality Director, Pharmacovigilance Lead
